Write your message
Volume 11, Issue 6 (November-December 2017)                   IJT 2017, 11(6): 33-36 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazemifar A M, Mojdehipanah H, Arami M, Khamesi S. Chronic Arsenic Toxicity from Drinking Well Water in a Rural Area. IJT. 2017; 11 (6) :33-36
URL: http://ijt.arakmu.ac.ir/article-1-623-en.html
1- Department of Internal Medicine, College of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
2- Department of Neurology, College of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran. , dr.houshmand@yahoo.com
Abstract:   (1291 Views)
Background: Drinking water is the most important cause of poisoning in the world. Iran is one of the countries with arsenic-contaminated water upper limit of normal. In this study, we decided to determine the effects of chronic arsenic poisoning on demographic, clinical and laboratory features of people.
Methods: This descriptive-sectional study carried out on all people resided in Shahidabad Village, Qazvin Province in 2015. All of them were evaluated in terms of demographic features, blood pressure, diabetes, dermatologic, and neurologic lesions, and fasting blood sugar. People with exclusion criteria were excluded. The data were analyzed by SPSS software and descriptive statistics.
Results: Out of 400 subjects, 278 (69.5%) females and 122 (30.5%) males), 88 (22%) people had positive urine test for arsenic and 312 (78%) subjects had negative urine test. The mean age of them was 48.9± 16.6 yr. The mean age and duration of residence in the region in arsenic positive group were significantly higher than arsenic negative group (P<0.05). Blood pressure, history of diabetes, dermatologic and neurologic lesions, and fasting blood sugar had no significant differences between two groups.
Conclusion: Although there were no significant differences between two groups in terms of many clinical and laboratory findings but the prevalence of 22% of poisoning with arsenic in the selected population reveals the necessity of screening, preventive measures and appropriate treatments in people exposed to arsenic contamination.
Full-Text [PDF 328 kb]   (491 Downloads)    
Type of Study: Research | Subject: General

1. Chakraborti D, Rahman MM, Paul K, Chowdhury UK, Sengupta MK, Lodh D, et al. Arsenic calamity in the Indian subcontinent: what lessons have been learned? Talanta 2002;58(1):3-22. [DOI:10.1016/S0039-9140(02)00270-9]
2. Datta D, Mitra S, Chhuttani P, Chakravarti R. Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut 1979;20(5):378-84. [DOI:10.1136/gut.20.5.378]
3. Guha Mazumder DN, Chakraborty AK, Ghose A, Gupta JD, Chakraborty DP, Dey SB. Chronic arsenic toxicity from drinking tubewell water in rural West Bengal. Bull WHHO 1988; 66 (4): 499-506.
4. Lemaire M, Lemarié CA, Flores Molina M, Schiffrin EL, Lehoux S, Mann KK. Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE−/− mouse model. Toxicol Sci 2011;122(1):211-21. [DOI:10.1093/toxsci/kfr097]
5. Petrusevski B, Sharma S, Schippers JC, Shordt K. Arsenic in drinking water. Delft: IRC International Water and Sanitation Centre 2007;17(1):36-44.
6. Tseng C-H. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 2008;199(1):12-8. [DOI:10.1016/j.atherosclerosis.2008.02.013]
7. Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B, et al. Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 2006:142-63.
8. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D, et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary. J Toxicol Clin Toxicol 2001;39(7):683-700. [DOI:10.1081/CLT-100108509]
9. Mosaferi M, Taghipour H, Hassani A, Borghei M, Kamali Z, Ghadirzadeh A. Study of arsenic presence in drinking water sources: a case study. Iran J Health Environ 2008;1(1):19-28.
10. Chiou H-Y, Chiou S-T, Hsu Y-H, Chou Y-L, Tseng C-H, Wei M-L, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001;153(5):411-8. [DOI:10.1093/aje/153.5.411]
11. Yoshida T, Yamauchi H, Sun GF. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 2004;198(3):243-52. [DOI:10.1016/j.taap.2003.10.022]
12. Mosaferi M, Yunesian M, Dastgiri S, Mesdaghinia A, Esmailnasab N. Prevalence of skin lesions and exposure to arsenic in drinking water in Iran. Sci Total Environ 2008;390(1):69-76. [DOI:10.1016/j.scitotenv.2007.09.035]
13. Mahram M, Shahsavari D, Oveisi S, Jalilolghadr S. Comparison of hypertension and diabetes mellitus prevalence in areas with and without water arsenic contamination. J Res Med Sci 2013;18(5):408-9.
14. Maharjan M, Shrestha RR, Ahmad SA, Watanabe C, Ohtsuka R. Prevalence of arsenicosis in Terai, Nepal. J Health Popul Nutr 2006:246-52.
15. Cheng T-J, Chuu J-J, Chang C-Y, Tsai W-C, Chen K-J, Guo H-R. Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism. Toxicol Appl Pharmacol 2011;256(2):146-53. [DOI:10.1016/j.taap.2011.08.001]
16. Nurun Nabi A, Rahman MM, Islam LN. Evaluation of biochemical changes in chronic arsenic poisoning among Bangladeshi patients. Int J Environ Res Public Health 2005;2(3):385-93. [DOI:10.3390/ijerph2005030002]
17. Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, et al. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect 2013;121(7):832-3. [DOI:10.1289/ehp.1205797]
18. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008;300(7):814-22. [DOI:10.1001/jama.300.7.814]
19. Kim NH, Mason CC, Nelson RG, Afton SE, Essader AS, Medlin JE, et al. Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians. Am J Epidemiol 2013;177(9):962-9. [DOI:10.1093/aje/kws329]
20. Díaz-Villase-or A, Burns AL, Salazar AM, Sordo M, Hiriart M, Cebrián ME, et al. Arsenite reduces insulin secretion in rat pancreatic β-cells by decreasing the calcium-dependent calpain-10 proteolysis of SNAP-25. Toxicol Appl Pharmacol 2008;231(3):291-9. [DOI:10.1016/j.taap.2008.05.018]
21. Chen Y, Ahsan H, Slavkovich V, Peltier GL, Gluskin RT, Parvez F, et al. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect 2010;118(9):1299-300. [DOI:10.1289/ehp.0901559]
22. Tseng W-P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977;19:109-10. [DOI:10.1289/ehp.7719109]
23. Tseng H-P, Wang Y-H, Wu M-M, The H-W, Chiou H-Y, Chen C-J. Association between chronic exposure to arsenic and slow nerve conduction velocity among adolescents in Taiwan. J Health Popul Nutr 2006:182-9.
24. Murphy MJ, Lyon L, Taylor J. Subacute arsenic neuropathy: clinical and electrophysiological observations. J Neurol Psychiatry 1981;44(10):896-900. [DOI:10.1136/jnnp.44.10.896]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb